Insights On Trial Design

  1. Analytics And Metrics Help Pinpoint Costs Of Study Startup

    Learn how by embracing a systematic, data-driven approach, it is possible for metrics to identify more accurately the best sites, steps causing delays, the associated costs, and why this is happening.

  2. Companion Diagnostic Development: Current Trends And Recommendations

    Learn six strategies for success when developing your companion diagnostic.

  3. Age Diversity In Clinical Trials: Addressing The Unmet Need

    In a recent New York Times article, Paula Span raises the concern that elderly subjects are frequently omitted from clinical trials.  Consequently, physicians know very little about how a given treatment may affect their older patients.  Is a medication effective for the elderly?  Is it safe?  Without data, how is a physician to know?  

  4. The Importance Of Real World Evidence In Oncology

    There is a significant need to collect Real World Evidence (RWE) to demonstrate the benefit of these drugs in clinical practice which can then be used as the wrap around to demonstrate true clinical benefit and address all stakeholder needs.

  5. Minimal Residual Disease Detection: Key Considerations For Clinical Development In Oncology

    Current MRD detection landscape, key considerations for each approach, and current advancements that will contribute to further improvements in MRD detection.

  6. The Power Of The Central Laboratory For Immuno-Oncology Drug Development

    Sponsors who partner with a global central laboratory should expect optimized outcomes resulting from a depth of immuno-oncology and technological expertise and harmonized processes.

  7. Advances In Seasonal Influenza Vaccine Development

    Learn 6 critical ways to keep track of the flu to optimize your seasonal flu vaccine development clinical trials.

  8. Harnessing Innovative Technologies For Clinical Trials Involving Emerging And Re-Emerging Infectious Diseases

    This white paper highlights the challenges of emerging and re-emerging infectious diseases such as TB, MSSA/MRSA, and Ebola.

  9. What Motivates Patients To Participate In Multiple Clinical Trials?

    Successful clinical trial recruitment requires a thorough understanding of the target patient profile, and a key factor within this profile is patient motivation. What drives a patient to consider, then subsequently inquire, prescreen, and finally consent and participate in a trial? While these motivations will vary by previous research experience, indication or condition, study type, patient demographics, and other elements, common themes often emerge when one speaks to patients directly about their reasoning.

  10. Six Trends Shaping Tomorrow's Clinical Trials

    Due to the continuous growth in drug development costs, there has never been a greater need for new and innovative ways to support the clinical trial supply chain. Explore key trends that are pushing the innovation envelope.